Dr. Hu on Active Surveillance for Prostate Cancer
Jim Hu, MD, MPH, director of the LeFrak Center for Robotic Surgery at Weill Cornell Medicine/NewYork-Presbyterian Hospital and the Ronald Lynch Chair of Urologic Oncology at Weill Cornell Medical College, discusses active surveillance for patients with prostate cancer.
Jim Hu, MD, MPH, director of the LeFrak Center for Robotic Surgery at Weill Cornell Medicine/NewYork-Presbyterian Hospital and the Ronald Lynch Chair of Urologic Oncology at Weill Cornell Medical College, discusses active surveillance for patients with prostate cancer.
With the increased utilization of active surveillance, patients with prostate cancer are less likely to be overdiagnosed and overtreated. The health literacy of the patient and their family on the risks and benefits of screening will lead to a better individualized choice.
